Biocon Biologics has secured full and exclusive global rights to its biosimilar Adalimumab, marketed as Hulio, strengthening its control over one of the world’s most widely used biologic therapies. The rights were obtained through an expande...
AstraZeneca has announced that its LATIFY phase III trial didn't work out as planned. The trial was testing ceralasertib mixed with Imfinzi (durvalumab) against the usual docetaxel treatment for patients with non-small cell lung cancer (NSCLC) that h
Glenmark Pharmaceuticals, USA, has announced the commercial launch of its epinephrine injection USP, 30 mg/30 mL (1 mg/mL) multiple-dose epinephrine vial in the US pharmaceutical market. The product expands Glenmark’s hospital injectables portfol...
Practo, a digital healthcare platform, plans to hit $1 billion in yearly gross merchandise value (GMV) by June 2026.
Emcure Pharmaceuticals is launching Poviztra, a new version of Novo Nordisk’s GLP-1 weight management drug, in India. This move increases Emcure's role in the quickly growing market for obesity treatments
Bharat Biotech signs a tech transfer deal with Biofabri to develop and supply the MTBVAC tuberculosis vaccine, supporting global TB control and Phase III trials.
The Indian Pharmaceutical Alliance (IPA) has revealed $15 million expenditure to build a dedicated pharmaceutical quality institute in Ahmedabad.
Merck has revealed a historic deal with the American government meant to increase prescription drug access for American consumers while simultaneously lowering costs.
The Most Favoured Nation (MFN) drug pricing policy proposed in the United States is not expected to have an immediate impact on Indian pharmaceutical companies, according to industry analysts and market experts. The policy seeks to align US prescr...
Cipla partners with Pfizer to exclusively market five established brands in India, strengthening acute therapy presence and expanding patient access through a nationwide distribution network.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")